SARS-CoV-2 Nucleocapsid Protein (Omicron B.1.1.529 Variant)
260€ (50 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
SARS-CoV-2 Nucleocapsid Protein (Omicron B.1.1.529 Variant)
category
Proteins and Peptides
provider
Abbexa
reference
abx620093
tested applications
SDS-PAGE
Description
SARS-CoV-2 Nucleocapsid Protein (Omicron B.1.1.529 Variant) is a recombinant protein expressed in E. coli.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Proteins and Peptides |
| Immunogen Target | SARS-CoV-2 Nucleocapsid Protein (Omicron B.1.1.529 Variant) |
| Host | E. coli |
| Assay Type | Sequence Fragment: Met1-Ala419 Tag: N-terminal His tag |
| Origin | Virus |
| Observed MW | Calculated MW: 46.31 kDa |
| Expression | Recombinant |
| Purity | > 90% (SDS-PAGE) |
| Size 1 | 50 µg |
| Size 2 | 100 µg |
| Size 3 | 1 mg |
| Tested Applications | SDS-PAGE |
| Buffer | Prior to lyophilization: PBS, pH 7.5, 0.02 % NLS, 1mM EDTA, 4 % Trehalose, 1 % Mannitol |
| Availability | Shipped within 5-10 working days. |
| Storage | Store at -20 °C to -80°C. Avoid repeated freeze/thaw cycles. Shelf Life: 12 months. |
| Dry Ice | No |
| NCBI Accession | UFO69279.1 |
| Background | Protein SARS-CoV-2 |
| Status | RUO |
| Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. Standard Form: A DNA sequence encoding the SARS-CoV-2 Nucleocapsid (YP_009724397.2, with mutations P13L, ERS31-33 deletion, R203K, G204R) (Met1-Ala419) was expressed with a polyhistidine tag at the N-terminus. The mutations were identified in the SARS-CoV-2 variant (known as variant B.1.1.529) which emerged in the South Africa. |
Descripción
Related Products
Human anti-SARS-CoV2 (N) IgG ELISA Kit
Ver Producto
Human anti-SARS-CoV2 (N) IgM ELISA Kit
Ver Producto